Public research footprint of Prisma Health, compiled from the ClinicalTrials.gov public registry.
Acute Myeloid Leukemia · Lung Non-Small Cell Carcinoma · B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 · EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Enter your work email to view the full list.
Verify and correct how your facility appears in public registry records — free.
Verify this profile →Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.